Answers are grounded in this paper and cite their sources.
At the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Conflicting points concerning drugs, carrier solution and optimal temperature for hyperthermic intraperitoneal chemotherapy (HIPEC) were discussed.
No takes yet. Share an insight, caveat, or question.
Kusamura et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: